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Abstract
Wagner, Jessica Ann. M.S., Department of Neuroscience, Cell Biology, and Physiology,
Wright State University, 2014.
Effects of Transcranial Direct Current Stimulation on Expression of Immediate Early
Genes (IEG’s)

Transcranial direct current stimulation (tDCS) has been utilized in human studies
to modulate a multitude of psychological, cognitive, and psychiatric disorders5. There
have been positive behavioral results in human subjects1, 2, 3, but our knowledge of
biological processes occurring during stimulation to elicit behavioral outcomes is limited.
Our study utilizes a rodent tDCS (R-tDCS) model in which Sprague Dawley rats receive
tDCS in order to examine whether tDCS affects neuronal activation. We examined two
immediate early genes (IEG’s), cFos and zif268, in order to discern if tDCS affects
neuronal activation. Our findings indicate that tDCS does affect neuronal activation by
means of IEG induction and that there is dose dependence between current intensity used
and mRNA levels of IEG’s. These findings are important because they show biologically
tDCS affecting neuronal activation. This study aided the scientific community in better
understanding what is occurring biologically during tDCS.
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Introduction
tDCS:
Transcranial Direct Current Stimulation (tDCS) is a novel non-invasive brain
stimulation (NIBS) procedure that has shown evidence of enhancing cognitive
capabilities in human subjects1, 2, and 3. Studies have also shown tDCS can produce
positive outcomes in treating depression, addiction, anxiety disorders, pain, and
schizophrenia5. tDCS is a protocol involving sub threshold current flowing across the
scalp, which can penetrate the skull and current flows across brain. Being a sub threshold
current, it does not elicit an action potential event, but may modulate the firing rate of
existing signaling pathways4. There are two types of tDCS stimulations: anodal, or
negative current, and cathodal, or positive current. Anodal stimulation conventionally is
excitable, while cathodal diminishes this effect4. tDCS can induce excitability in the
human motor cortex upon anodal tDCS treatment and this excitability can be abolished
with an NMDA receptor antagonist4. These results indicate that anodal tDCS treatment is
dependent upon NMDA activity. This indicates that tDCS is a NMDA dependent
treatment, and to further investigate what occurs biologically we want to examine NMDA
dependent pathways.
Recent studies show a positive correlation between tDCS treatment and
enhancement of cognitive performance1, 2, and 3. Although behavioral outcomes are of
interest, we need to determine which biological processes are modulated before moving
forward with tDCS. The studies to report cognitive enhancement were conducted in
humans, limiting what can be analyzed molecularly at this point, and we propose a rodent
1
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tDCS (R-tDCS) model that will aid in the understanding of biological pathways involved
with tDCS. It is apparent from human studies tDCS after-effects are dependent upon the
NMDA receptor activity4. These after-effects of tDCS are thought to result from
modulation of neuronal activity6, 7, and 8. tDCS is thought to affect neuronal activation,
therefore we are studying whether tDCS modulates neuronal activity via immediate early
genes IEG’s (Immediate Early Genes): cFos and zif268.
Other brain stimulation techniques have looked at IEG transcript changes, but
none due to tDCS. Experiments in TMS (transcranial magnetic stimulation) show
differential expression of zif268 and cFos due to stimulation9. Both genes responded to
stimulation, but to different stimulation parameters. Another study focused on cFos and
zif268 in response to direct current stimulation (DCS) in rat hippocampal slices which,
showed responses of both genes in the hippocampus10. Histological studies have been
conducted in rodent models of tDCS, show that increasing current intensity will increase
the probability of stimulation producing lesions11. We are examining biological effects to
increases in current intensity which has not been shown prior to this study. These studies
show positive induction of cFos and zif268, which we hypothesized, would also respond
to tDCS treatment. So far, neither cFos nor zif268 have been examined following tDCS
treatment at varying current intensities.

Neuronal Activation:
Since the beginning of tDCS research, studies have investigated whether tDCS
modulates neuronal activity. tDCS has been shown to modulate neuronal firing12 and
2
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amplitude of evoked action potentials8 . These results were obtained using
electrophysiological experiments, and we plan to answer this question by examining
biological markers of neuronal activation. The polarizing current of tDCS is thought to
modulate neuronal activity by changing the membrane potential and increasing the
stochastic firing rate of neurons13. We plan to investigate the relationship between tDCS
and neuronal activation by examining two IEG’s cFos and zif268. IEG’s are known to be
some of the first genes transcribed during activation, so they are the ideal candidates to
investigate this question. The IEG’s become induced in response to secondary
messengers activating kinases. Once the IEG’s are transcribed and translated into DNA,
they can re-enter the nucleus and cause the induction of novel gene transcription (Figure
1). As stated earlier, there has been research with electrophysiological experiments, but
we think it is also important to measure the biological markers that are being activated in
order to fully understand the biological processes occurring. We hope to gain information
about tDCS that we are unable to obtain in human subjects.
cFos and zif268 have been modulated by other activation evoking stimuli, so we
believe if tDCS does modulate neuronal activation we will be able to capture this with the
induction of IEG’s. By measuring the transcript expression levels of cFos and zif268 we
will be able to discern which areas are being activated, and hopefully be able to follow
the current path into the brain.
Immediate Early Genes:
IEG’s are recognized as genes that are transiently transcribed and independent of
de novo protein synthesis to be transcribed14. IEG induction occurs with an array of
3
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stimuli, indicating that they part of the first wave of genetic responses15, 16. There are two
types of IEG subclasses: regulatory transcription factors and effectors. The regulatory
transcription factors (RTFs) act as transcription factors to downstream elements involved
in modifying the phenotype of the cell15, 16. Once translated, these proteins can re-enter
the nucleus and up-regulate the transcription of de novo downstream elements (Figure 1).
Since the nature of IEG genes is to respond rapidly, we anticipate following tDCS
treatment we will see modulation in mRNA levels of these genes. The transcription of
IEGs, mainly RTFs, in early phases of cellular activation is thought to contribute to
transcriptional changes seen in subsequent phases17. The IEG’s we examined are RTF’s,
which can rapidly recruit transcription apparatuses to promoter sites of target genes18.
Zif268 and cFos are highlighted because they belong in the RTF subclass of IEG’s,
meaning they are the first wave of genetic transcription. The IEG’s, cFos and zif268, are
ideal candidates to study how tDCS affects neuronal activation.

4
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Figure 1: Schematic of IEG induction. An extracellular molecule
interacts with a cell surface receptor which can trigger secondary
messengers to begin the pathway. IEG’s can enter the nucleus, bind to
DNA and induce novel gene transcription. The early phase requires
responses from protein kinases, while the late response requires
transcriptional changes.
Zif/268:
Zif268 is an IEG which encodes a zinc finger protein that acts as a transcription factor.
The gene plays a crucial role in LTP (Long-Term Potentiation), mainly the transition
between early and late phase LTP17. Without the expression of zif268 the long term
memory consolidation of the individual diminishes, thus demonstrating the role of this
gene for LTP maintenance17. We are studying this gene since it produces a robust and
rapid response to LTP inducible stimuli19 and has been shown to respond under the
behavioral environment in which tDCS is administered20. Zif268 has also shown a
dependence on NMDA activity and highly correlated with LTP events32. This IEG is of

5
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interest because of its dependence on NMDA, since tDCS studies in humans have shown
a dependence of after-effects with NMDA activation.
cFos:
cFos is part of a protein family that forms complexes with Jun, which constitute the
activator protein (AP-1)21. cFos is an IEG that has shown up-regulation due to a
multitude of stimuli22, examples including: activation in olfactory bulbs due to scent23,
expression in striatum due to caffeine intake26, and activation in auditory cortex due to
auditory cues27. cFos is able to auto-regulate itself, by a negative feedback loop15.
Research shows that in the presence of protein synthesis inhibitors, cFos expression is
super induced, indicating the de novo protein synthesis is needed to shut off cFos
expression15. cFos is also an ideal marker for neuronal activation, in which its expression
increases in brain regions when exposed to associated stimuli23. Also, cFos is unique
from other IEG’s in that its basal levels are relatively low, there is a broad range of
mRNA levels, and both mRNA and protein have a short half-life24. This aspect of cFos
makes it easier to capture, since there is such a broad range of transcript levels
researchers can observe changes.
Current Intensity
In our animal model we wanted to determine the effects of varying current
intensities with the expression of cFos and zif268. With varying current, from highest
setting (2,500 µA) to our awake stimulation current (75 µA), we want to determine
changes of zif268 and cFos expression in terms of transcription levels and with zif268
protein expression. Studies have been performed to determine safety levels of tDCS in
6
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rodents11. While the Liebtanz study concentrates on lesion size occurring at high current
intensities; we want to focus on genetic changes occurring at these intensity levels.
Liebtanz’ s study was important since it was the first to evaluate tDCS current safety
levels in rodents, giving researchers a better range of current intensities to utilize.
Researchers have shown evidence indicating that the current dosage effects may
not be a linear relationship25. This study showed that above a threshold value, in their
study 2,000 µA, the effects seen were opposite of what is expected; at 2,000 µA cathodal
current induced excitation, instead of the expected inhibition25. Being able to describe
biologically this relationship between current intensity dosage and IEG effects can help
the community better understand the dose curve of tDCS treatment. We aim to find an
intensity that does not cause damage, but has robust changes in zif268 and cFos
expression. Also in concurrence with the zif268 and cFos we hope to show that tDCS
treatment can lead to changes in cortex, as well as hippocampal region. We are
hypothesizing that changes in zif268 and cFos expression will increase with increasing
current intensity.

7
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Methods
Animals:
Male Sprague Dawley rats (Charles River) between 300-500 g were utilized for this
study. Animals were quarantined for 10 days upon entry in an AAALAC (Association for
Assessment and Accreditation of Laboratory Animals) accredited animal facility and
were doubly housed with ad libitum access to food and water. All testing was conducted
during the light cycle. All procedures were approved by the Wright-Patterson Air Force
Base (WPAFB) Institutional Animal Care and Use Committee and performed in
accordance with the National Institute of Health standards and the Guide for the Care and
Use of Laboratory Animals (National Research Council, 2011).
Surgeries:
Animals underwent surgery in order to place the head electrode 2.5mm caudal bregma.
Animals were anesthetized with isoflurane (Piramal) at an average of 2-3%. An incision
was made to expose skull, and head electrode (approximately 25 mm2; Avelgaard
Manufacturing Factory ltd) was placed 2.5mm caudal bregma and held in place by a head
clamp (AFRL). C&B Metabond Adhesive Luting Cement (Parkell Inc.) was added to
electrode and clamp, and allowed 5 minutes to dry. Acrylic (Henry Shein), was added
over cement in order to maintain integrity of the electrode connection. Once the acrylic
hardened, the head incision was sutured closed and animals were placed back in home
cage. Animals recovered uneventfully at least 7 days before tDCS treatment.

8
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tDCS Treatment:
Animals were brought into the behavioral room a couple minutes before tDCS began.
The reference electrode was attached between shoulders with Signagel electrode gel
(Parker Laboratories) and held in place with Petflex cohesive bandage (Andover). The
animal was placed in a novel object arena (40.5 cm x 45 cm x 36 cm Plexiglas), with
three novel objects. Fishing line was used to hold a washer, diameter 2.5 cm, above arena
in order to feed reference and head electrode wires through in order to stay out of reach
of animal. Animals were freely able to explore environment. A resistance measure was
taken with an impedance meter (Grasstechnologies) in order to check the status of the
head electrode connection and if under 150 kΩ the animal would precede to tDCS
treatment. Using a Magstim DC-stimulator (Neuroconn) tDCS treatment was applied.
Between animals the arena was cleaned with 50% ethanol. For anode stimulation the
head received the negative current while the reference electrode received the positive
current. In the sham group the electrode wires were connected to the Magstim DCStimulator but no stimulation occurred. Animals received anodal (75 µA) or sham (0 µA)
stimulation for 20 minutes, and were placed back in their home cage after treatment. For
immunohistochemical collection, animals were euthanized immediately following
treatment; RNA animals were euthanized 20 minutes following end of stimulation
(Figure 2).
In anesthetized experiments animals were brought into the procedure room and
anesthetized with 2-3% isoflurane (Piramal). Once the animals were determined to be
9
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anesthetized it was moved to a nose cone and remained under isoflurane for the entire
procedure. For immunohistochemical animals, stimulation duration was 60 minutes
(Figure 2) followed by euthanasia immediately upon completion of stimulations. RNA
animal’s stimulation duration was 20 minutes and sacrifice occurred 20 minutes poststimulation. The current intensities applied for immunohistochemical experiments were:
0µA, 150 µA, 300 µA , 500 µA, 1000 µA, 2,500 µA (Table 1). The current intensities
used for the RNA experiment were: 0µA, 250 µA, 500 µA, 2,000 µA (Table 1).

IHC Collection

Awake Animals

Stimulation

RNA Collection

20 min

Anesthetized Animals

20 minutes

Stimulation

IHC Collection

60 min
20 minutes

Stimulation

RNA Collection

20 min

Figure 2: Experimental Design. Awake animal experiments have
same experimental design for IHC and RNA collection. Anesthetized
animals have two experimental designs split between IHC and RNA
collection

10
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Experiment

Animal State

Awake

1

Experiment

Stimulation RNA/IHC

Groups

Time

CON, 0µA, 75

20 min

RNA

20 min

IHC

60 min

IHC

µA
Awake

1

CON, 0µA, 75
µA

Anesthetized

2

0µA, 150µA,
300 µA

2

Anesthetized

500µA, 250 µA

60 min

IHC

3

Anesthetized

0µA, 250µA,

20 min

RNA

500µA,
2,000µA
Table 1: Experimental outline of animal consciousness, current
intensities, and experimental type (RNA or IHC)

Euthanasia
Means of euthanasia depended on the experiment to be conducted with the tissue. All
RNA animals were euthanized by means of rapid decapitation. Tissue was dissected and
frozen immediately. All immunohistochemical animals were injected with 0.001-0.002%

11
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body mass of euthasol and perfused with 150-200mL 1X PBS followed by 150-200mL
4% PFA. All euthanasia techniques were in accordance with AVMA guidelines (2013).

Transcript level expression:
After animal euthanasia, the brain was removed from the skull and sectioned on rat brain
matrix (Zivic Instruments). After the slice was removed cortex regions and hippocampi
were dissected, placed in an RNase free tube, and immediately put on dry ice and stored
at -80°C. RNA extraction utilized RNeasy Mini Kit (Qiagen) following manufacturers
protocol. For RNA quality the Nanodrop (Nanodrop 100 Spectophotometer,
ThermoScientific) was utilized and concentration was used to normalize samples before
cDNA synthesis. The High Capacity RNA to cDNA kit (Applied Biosystems) was used
to synthesize 500 ng of RNA into cDNA. cDNA product was then used for quantitative
real-time PCR (qRT-PCR, Figure 4) which was performed on StepOne Plus PCR
Machine (Applied Biosystems) while using Fast SYBR Green Master Mix kit protocol
(Applied Biosystems, Figure 3).

12
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Applied Biosystems FAST SYBR Green

Figure 3: Representation of chemical reaction of
SYBR Green 1 dye with double-stranded DNA
during PCR
The primers (Eurofins MWG Operon) used with the reaction were as follows: Hprt1
forward 5’GACCAGTCAACGGGGGACAT 3’ and reverse
5’GGGGCTGTACTGCTTGACCA 3’, EDA forward 5’
AGTAGGCGTGTTCGCCGCAA 3’ and reverse 5’ GTCCCTGGGGTCCTGGAGGT 3’,
cFos forward 5’CAAGGACCCTGACCCCATAGT 3’ and reverse
5’GATACGCTCCAAGCGGTAGGT 3’, and zif268 forward
5’GAAAGCCCTTCCAGTGTGGAATCTG3’ and reverse
5’GGAAGAGGCAGCTGAGGAGGCCAC3’. Melt curve analysis was taken into
account (StepOne Plus, Applied Biosystems) to determine the reaction integrity. All
reactions had a single peak in melt curves indicating a pure product. Fold changes were
calculated using ∆∆CT Comparative method with endogenous control value averaging CT
values of Hprt1 and EDA . Fold changes were analyzed by a 1-way-ANOVA to
determine group differences.

13
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Applied Biosystems

Figure 4: Schematic of steps involved with qRT-PCR

Validation of Primers
Primers were designed using Primer Blast (NCBI) in which primers were chosen if they
meet the following criteria: GC criteria below 60%, Tm temperature near 60°C, and
primer needed to stretch across two exons. At minimum 3 primers were chosen in order
to perform optimization experiments. First primers were run at various temperatures
(55°C-65°C) to determine which temperature yielded the lowest Ct values indicating
maximal performance. Next melt curves were examined to see if primers yielded one
pure product. If the primers passed the previous criteria, then a serial dilution PCR
experiment was run in order to determine the efficacy of the reaction. Primers were
selected that had an efficacy values between 90-100%.

14
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ΔΔCt Comparative Method:
The analysis method for mRNA experiments utilized the ΔΔCt method to determine
differences in fold changes. This method compares between endogenous control genes
and target genes to determine the fold change difference between groups. The threshold
value (Ct) is the value in which the reaction begins its exponential phase. Each sample
was first normalized to their own endogenous control Ct value, which was the average of
Hprt1 and EDA Ct values. The normalization equation is:
∆𝐶𝑡 = 𝐶𝑡 𝑡𝑎𝑟𝑔𝑒𝑡 𝑔𝑒𝑛𝑒 − 𝐶𝑡 𝑒𝑛𝑑𝑜𝑔𝑒𝑛𝑜𝑢𝑠 𝑐𝑜𝑛𝑡𝑟𝑜𝑙

This value is called the ΔCt value. The next normalization is compared against the
average ΔCt of the control group; in experiment one it was the cage control group and in
experiment three it was sham. The equation to calculate this value is:
∆∆𝐶𝑡 = ∆𝐶𝑡 𝑡𝑎𝑟𝑔𝑒𝑡 𝑔𝑒𝑛𝑒 (𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑔𝑟𝑜𝑢𝑝) − ∆𝐶𝑡 𝑒𝑛𝑑𝑜𝑔𝑒𝑛𝑜𝑢𝑠 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 (𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑔𝑟𝑜𝑢𝑝)

This accounts for the difference in ΔCt values of the target gene in both treatment and

control groups. To calculate the fold change, we used the equation:
𝐹𝑜𝑙𝑑 𝐶ℎ𝑎𝑛𝑔𝑒 = 2−∆∆𝐶𝑡

Values that were more than 2 standard deviations away from the group mean were
eliminated from further analysis.
Melting Curve Analysis:
To insure the integrity of the PCR reaction a melt curve analysis was run in order to
verify the existence of one pure product. At the end of the PCR reaction all the copies of
15
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transcript are in double strand form, meaning SYBR is bound and there is high
fluorescence. The melt curve takes a fluorescence measurement every 0.3°C and
increases from 65°C to 95°C. The program indicates a melting temperature when the
fluorescence drops suddenly, indicating the double stranded DNA has dissociated. This
technique is standard protocol when utilizing SYBR Green fluorescent marker for qRTPCR reactions.
Immunohistochemical experiments:
Animals were perfused with ~150mL of 1 X PBS followed by ~150 mL of 4%
paraformaldehyde (PFA). After perfusion the brain was extracted and stored in 4% PFA
at 4° C for 24 hours. After allotted time the brain was removed from PFA solution and
placed in a 30% sucrose solution for several days until brain ceased floating. Once the
brain sank to the bottom of the tube it was determined to be ready to section. Brains were
sliced frozen at a thickness of 16 μM on Leica SM2010R Micro-tome (Leica Biosystems)
at an average temperature of -30°C. Slices were transferred to a cyroprotectant solution
(0.1M Na Phosphate Buffer at 7.2 pH, polyvinylpyrolidine, ethylene glycol, and sucrose)
and stored at -20°C until needed for staining protocol. Following removal from
cryoprotectant, sections were washed 5 times for 5 minutes in 1X Phosphate Buffer
Saline solution (PBS). After washing the sections were blocked for 1 hour in Blocking
Buffer (1X PBS, 100X Triton, and Goat Serum). Primary antibodies were added to the
blocking buffer solution and incubated at 4°C overnight. Primary antibodies utilized were
rabbit anti-zif268 (dilution 1:1,000, Santa Cruz Biotechnology), and mouse anti-NeuN
(dilution 1:12,500, Millipore). After primary antibody incubation sections were washed
again in 1X PBS 5 times for 5 minutes. Blocking buffer and secondary antibodies were
16
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added at this time and incubated in the dark at room temperature for one hour. Secondary
antibodies utilized were Alexa-Fluor488 goat anti-rabbit (dilution 1:500, Jackson
ImmunoResearch, Figure 6) and AlexaFluor594 goat anti-mouse (dilution 1:500, Jackson
ImmunoResearch). Once secondary incubation was complete slices were washed again in
1X PBS 5 times for 5 minutes. Then, a final wash was performed in 0.1M Phosphate
Buffer (PB) for 5 minutes before sections were mounted on the slides. The mounting
media used was Fluoromount (Sigma-Aldrich) and slides were cover slipped and sealed.

Immunohistochemical Data collection
For hippocampal CA1, images were stitched using the pairwise stitch plugin
provided by ImageJ35. CA1 images were manually counted by 3 scorers, in which median
value was used. Scorers counted number of NeuN labeled cells, followed by number of
co-localized cells indicated by yellow stain (NeuN= red and zif268= green, Figure 7).
For the cortex regions, NeuN labeled cells were counted via ImageJ ‘Analyze Particles’
program. The regions of colocalization were identified utilizing the colocalization finder
plugin for ImageJ. The percent expression of zif268 was computed by dividing the
number of colocalized cells by number of NeuN labeled cells.
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A

Somatosensory Cortex

Experiment 1: RNA
Hippocampus

C

B

CTX1

Central Cortex
CTX (lateral)

Hippocampus
CTX2

CTX3

Figure 5: Region of interest for each
experiment. Images provided by
brainmaps.com. Panel A) Experiment
One RNA experiments, Panel B) all IHC
experiments, and Panel C) Experiment
three RNA experiments
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Alexa-Fluor 488 Goat
anti-rabbit

Figure 6: Immunohistochemistry reaction
schematic. Example being labeling of zif268 protein.
Statistical Analysis:
All statistical analysis was completed using SigmaPlot (Version 4.17) and a 1-way
ANOVA was run to verify group differences between mRNA fold changes and protein
expression levels. If normality failed, a ranked 1-way ANOVA was used to analyze
results. A 2-way ANOVA was run to determine differences between brain regions and
treatment groups. To determine whether the mRNA hippocampal data from experiment
three could be combined, a two- tailed two- sample t-test was run to verify differences
between groups. Significance was based off a p-value <.05.
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Figure 7: Result of immunohistochemical experiments. The red cells are NeuN
stain, green zif268 stain, and yellow is the colocalization of the two antibodies
indicating neurons expressing zif268. Arrows indicate examples of double labeled
cells.
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Results
tDCS treatment in awake animal:
Animals received stimulation (SHAM or 75 µA) for 20 minute duration while
awake in novel environment. The transcript levels of cFos and zif268 were measured
with zif268 showing an increase in transcript for both SHAM and 75 µA groups (p <
0.05) compared to cage control animals in both hippocampus and somatosensory cortex
regions (Figure 8). Fold change values for zif268: CON 1.04 (SE± 0.09), SHAM 2.86
(SE±0.27) and 75 µA 3.27 (SE±0.22) in the somatosensory cortex, and for the
hippocampus CON 1.01 (SE±0.05), SHAM 1.96 (SE±0.15) and 75 µA 2.00 (SE± 0.19);
the fold change values decrease from somatosensory cortex to hippocampus.

B) Hippocampus

4
3.5
3
2.5
2
1.5
1
0.5
0

2.5

* *

* *

2
Fold Change

Fold Change

A) Somatosensory Cortex

1.5
1
0.5

Hprt1

cFos

0

zif/268

Figure 8: A) mRNA levels in somatosensory cortex, B)
mRNA levels in hippocampus. *= p<0.05 vs. CON.

Hprt1

cFos

zif268

CON
SHAM
75 µA
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Zif268 Protein Response to Multiple Current Intensities:
Following previous experiment we questioned whether sufficient current was reaching
the brain. We decided to run an experiment where we would try to induce lesions
concurrently with looking at zif268 protein expression. Under anesthesia, we increased
the current intensity to 2,500 µA to the point where we could see lesions in H&E
staining. The nature of the lesion experiment was such that the ‘n’ was small.
Animals received stimulation (CON, SHAM, 75 µA) for 20 minutes in conscious
animals and in anesthetized state (SHAM, 150 µA, 300 µA, 500 µA, and 2,500 µA) for
60 minute. The first set of animals (CON, SHAM, and 75 µA) there was no main effect
across the CTX1 (F= 0.964, p= 0.414), CTX2 (F= 0.559, p= 0.589), CTX3 (F= 2.642,
p= 0.120), and CA1 (F=2.220, p= 0.159) with no clear relationship among current
intensity groups. (Figure 9). The second set of animals (SHAM, 150 µA, and 300 µA)
showed neither significance amongst groups or main effect for all brain regions (CTX1:
F= 2.937, p=0.119, CTX2: F= 0.558, p=0.599, CTX3: F= 0.239, p= 0.794, and CA1:
H=0.409, p= 0.848), but showed a trend of the 150 µA group having a higher proportion
of neurons expressing zif268 than 300 µA (Figure 10). Overall the SHAM group
consistently showed the largest proportion of neurons expressing zif268. The third set of
animals (500 µA and 2,500 µA) showed no significant difference between groups or a
main effect for all brain regions (CTX1: F= 0.0106, p= 0.925, CTX2: F= 7.297, p=
0.0704, CTX3: H= 0.000, p= 1.00, and CA1: F= 1.342, p= 0.330) (Figure 11). Overall
the two groups showed similar expression proportions between brain regions. The trend
observed from all the experiments is as the subsequent sets increase in current intensity,
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there is an increase in the amount of neurons expressing zif268. Next we wanted to
determine if we could see an effect with a similar experiment, except looking at RNA.

% neurons expression zif268

A) CA1- Hippocampus
20.0%
15.0%
10.0%
5.0%
0.0%

CON

SHAM

B) CTX1
% neurons expressing zif268

% neurons expressing zif268

10.0%
8.0%
6.0%
4.0%
2.0%
SHAM

% neurons expressing zif268

CON

C) CTX2

15.0%

12.0%

0.0%

75 uA

75 uA

10.0%
5.0%
0.0%

CON

SHAM

75 uA

D) CTX3

8.0%
6.0%
4.0%
2.0%
0.0%

CON

SHAM

75 uA

Figure 9: Zif268 protein expression levels with varying current intensities: 0 µA and
75 µA. Expression levels represented as % neurons expressing zif268. A) CA1
Hippocampus, B) CTX1, C) CTX2, and D) CTX3
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% neurons expressing zif268
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B) CTX1

40.0%

40.0%

30.0%

30.0%

20.0%

20.0%

10.0%

10.0%

0.0%
SHAM-a

150 uA

0.0%

300 uA

SHAM-a

150 uA

300 uA

D) CTX3
% Neurons expressing zif268
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Figure 10: Zif268 protein expression levels with varying current intensities: 0µA, 150 µA,
and 300 µA. Expression levels represented as % neurons expressing zif268. A) CA1
Hippocampus, B) CTX1, C) CTX2, and D) CTX3
.
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Figure 11: Zif268 protein expression levels with varying current
intensities: 500 µA and 2,500 µA. Expression levels represented as %
neurons expressing zif268. A) CA1 Hippocampus, B) CTX1, C) CTX2, and
D) CTX3

Transcript Response to Multiple Current Intensities:
Animals received stimulation (SHAM, 250 µA, 500 µA, or 2,000 µA) for 20
minutes under anesthesia. The transcript levels of cFos and zif268 were measured in the
following areas: centrally located cortex (CCTX), laterally located cortex (LCTX), right
HIP (RHIP), and left HIP (LHIP). The largest increase in transcript fold changed was
observed in CCTX (Figure 12) and decreased as regions moved further from CCTX. cFos
and zif268 both showed induction in CCTX with 2,000 µA group showing the largest
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increase in fold change of all brain regions, cFos 13.99 (SE± 1.934) and zif268 1.633
(SE± 0.095).
For cFos in the CCTX there was a main effect of H= 20.04, p< 0.001, with the
2,000 µA group being significantly different than Sham and 250 µA groups (Q= 4.43,
p<0.05 and Q= 2.82, p< 0.05). In the LCTX there was a main effect of H= 18.30, p<
0.001, with the 2,000 µA and 250 µA groups significantly different than the sham, Q=
4.20, p< 0.05 and Q= 2.49, p< 0.05, respectively. For RHIP and LHIP there was a main
effect observed, H= 15.10, p=0.002 and H= 16.62, p< 0.001 respectively, and the 2,000
µA group was significantly different than Sham, 500 µA, and 250 µA groups. For RHIP
statistical values yielded, Q= 3.46, p< 0.05 (2,000 µA vs. Sham), Q= 3.20, p< 0.05 (2,000
µA vs. 500 µA), and Q=2.79, p< 0.05 (2,000 µA vs. 250 µA). For LHIP the statistical
values were Q= 3.50, p< 0.05 (2,000 µA vs. Sham), Q= 2.81, p< 0.05 (2,000 µA vs. 500
µA), and Q= 3.35, p< 0.05 (2,000 µA vs. 250 µA).
For zif268 in the CCTX there was a main effect F= 18.37, p< 0.001 with the
2,000µA group being significantly different than the Sham, 250 µA and 500 µA groups
(t= 6.48, p<0.001, t=5.69, p< 0.001, and t=6.10, p< 0.001). In the LCTX there was a main
effect of F= 6.80, p= 0.002 with the 2,000 µA group being significantly different than
Sham, t= 3.72, p= 0.001, 250 µA, t= 3.83, p< 0.001, and 500 µA, t= 3.64, p= 0.001. For
RHIP and LHIP there were main effects, H= 9.10, p= 0.028 and F=7.31, p= 0.001
respectively. In the RHIP there were no significant differences between groups, but in the
LHIP there were significant differences in which 2,000 µA group was different than 250
µA (t= 2.83, p= 0.045) and 500 µA group (t= 4.63, p< 0.001).
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Figure 12: (a) cFos mRNA levels in Central Cortex, (b) zif268 mRNA levels
in Central Cortex. *= p<0.05 vs. Sham and ^=p<0.05 vs. 250µA and 500
µA, #= P<0.05 vs. 250 µA
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Figure 13: (a) cFos mRNA levels in Lateral Cortex, (b)zif268 mRNA
levels in Later Cortex. *= p<0.05 vs. Sham and ^= p<0.05 vs. 250 µA
and 500 µA.
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Figure 14: (a) cFos mRNA levels in hippocampus, (b) zif268 mRNA
levels in hippocampus. *= p<0.05 vs. Sham, 250 µA, and 500 µA. ^=
p<0.05 vs. 500µA and 250 µA.

Transcript changes across brain regions
To measure changes between brain regions a 2-way ANOVA was implemented. For cFos
a main effect was observed between brain regions yielding an F ratio of 25.52, p< 0.001
and an interaction between Current Intensity x Brain Region was observed, F= 11.80, p<
0.001. A post hoc test revealed fold changes in CCTX and LCTX were higher than those
in RHIP (t= 2.83, p< 0.001 and t=2.47, p< 0.001), and LHIP (t= 3.19, p< 0.001 and
t=2.85, p< 0.001). Within those groups results revealed that 2,000 µA group had higher
fold change values in CCTX and LCTX than RHIP (t= 7.60, p< 0.001 and t= 5.53, p<
0.001), and LHIP (t= 9.15, p< 0.001 and t= 6.94, p< 0.001).
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For zif268 a main effect observed between brain region, F= 12.30, p< 0.001 and an
interaction between Current Intensity x Brain Region F= 2.85, p= 0.002 showed
significance. Post hoc test showed fold changes in CCTX and LCTX were higher than
those in RHIP (t= 6.05, p<0.001 and t= 3.73, p= 0.002), and LHIP (t=4.10, p< 0.001 and
not significant against LCTX). Post hoc test also revealed changes in mRNA of current
intensities across brain regions. The 500µA group had higher fold change values in
CCTX compared to RHIP (t= 3.10, p= 0.024). The 2,000 µA group showed higher fold
change values in CCTX compared to RHIP ( t= 6.70, p< 0.001), LHIP ( t= 5.91, p<
0.001), and LCTX ( t= 2.87, p= 0.024).
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Figure 15: mRNA levels in all brain regions, A) cFos and
B) zif268. *= <0.001 vs RHIP and LHIP, ^ = <0.5 vs.
LCTX
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Discussion
The aim of this study was determine whether tDCS stimulation modulates
neuronal activation via IEG expression levels. IEG’s are ideal to study because they are
induced with different types of stimulation33 and are markers for neuronal activation.
This is an important topic, since prior to this cFos and zif268 have not been studied in
rodent tDCS models. Our results show that neuronal activation and the ability to
penetrate deeper regions is dependent on current intensity. This information is imperative
to move forward, because we have outlined the strength of current needed to penetrate
target regions (like the hippocampus) and have identified targets sensitive to tDCS
treatment.
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x

x
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x

x

x

x
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0.414

x

x

x

x
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0.620

-

x

x

x

x

Sham vs. 300 µA

0.16

0.346

0.521

-

x

x

x

x
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0.331

0.548
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-

x

x

x

x

0.925

0.074

-

0.33

x

x

x

x

Sham vs. 250 µA

x

x

x

x

0.805

0.968

0.213

0.774

Sham vs. 500 µA

x

x

x

x

0.694

0.824

0.197

0.145

Sham vs. 2000 µA

x

x

x

x

<0.001

0.001

0.897

0.109

250 uA vs. 500 µA
250 uA vs. 2000
µA
500 uA vs. 2000
µA

x

x

x

x

0.676

0.850

0.971

0.132

x

x

x

x

<0.001

<0.001

0.216

0.045

x

x

x

x

<0.001

0.001

0.223

<0.001

Sham vs. 250 µA

x

x

x

x

-

-

-

-

cFos
Sham vs. 500 µA

x

x

x

x

-

-

-

-

Sham vs. 2000 µA

x

x

x

x

<0.05

<0.05

<0.05

<0.05

250 uA vs. 500 µA
250 uA vs. 2000
µA
500 uA vs. 2000
µA

x

x

x

x

-

-

-

-

x

x

x

x

<0.05

-

<0.05

<0.05

x

x

x

x

-

-

<0.05

<0.05

Table 2: Summary of results. Bold values indicate significance. All cFos
experiments failed normality, so a ranked 1-way ANOVA was run. Notation of
‘x’ indicates comparison was not part of the experiment.

Neuronal Activation and tDCS
tDCS is thought to modulate behavioral outcomes in subjects by altering neuronal
activation of the stimulated area and the surrounding regions28. With two polarities of
stimulation, anodal and cathodal, the effect on neuronal activation is thought to be
inhibitory or excitatory13. In this study we investigate whether increasing anodal current
intensity will modulate neuronal activation via the IEG’s zif268 and cFos. Our results
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show that tDCS alone affects IEG transcript levels, but that the highest current intensity
of 2,000 µA, displayed the highest mRNA fold changes compared to the lower intensities
(Table 2). Also for this same group, it consistently showed a significant increase in fold
change for all brain regions. This indicates that at the highest current intensity, neuronal
activation occurs in a deep region, like the hippocampus. For cFos in the CCTX mRNA
fold changes for 2,000 µA showed a significant increase in mRNA levels compared to all
of current intensity groups (Figure 12a). For zif268 in all brain regions, only the 2,000
µA group showed a significant increase from sham and for CCTX and LCTX from the
other current intensities (Figures 12b, 13b, 14b).
IEGs are ideal to examine neuronal activation since these genes have been
involved in response to caffeine26, auditory cued fear conditioning27, and odor-induced
neuronal activation23. These genes have been involved with multiple types of stimulation;
usually involving the region associated with the stimulus22. This coincides with previous
research looking at how transcortical direct current affects neuronal activation via
amplitudes of evoked action potentials. Bindman showed that after 20 minute
stimulation, there was an increase in the peak amplitude of action potentials in the
somatosensory cortex8. Studies in humans examine motor evoked potentials (MEPs) in
individuals following anodal stimulation, showed that anodal stimulation displayed
higher MEP values than cathodal stimulation7; again with anodal tDCS we see an overall
increase in activity. Since we conventionally view neuronal activation as an increase in
stochastic firing rates4, 10, 13, our results support the electrophysiological results.
Concurrent with previous results, our data shows increases in neuronal activation markers
due to tDCS above the sham baseline levels.
33

Distribution A: Approved for public release; distribution unlimited. 88ABW Cleared 07/14/2014; 88ABW-2014-3350

Spread of tDCS current
With this study we have shown that there is a spread of tDCS current. In
experiment three, we examined three different brain regions: Central CTX (CCTX),
Lateral CTX (LCTX), and Hippocampus (HIP), in which the hippocampus was split into
right (RHIP) and left (LHIP) hemispheres. We chose these regions based off of the
electrode placement and distance from electrode. The order of regions from closest to
electrode site to farthest is: CCTX, LCTX, and HIP. For both cFos and zif268 in the
2,000 µA group, CCTX and LCTX showed a significant increase in mRNA fold change
compared to HIP (Figure 15). This indicates that as the current spread to deeper regions
the effect it elicits is less than being closer to stimulation site.
When looking at zif268, other current intensity groups showed significant
differences among brain regions. The 2,000 µA group was significantly higher than
LCTX, RHIP, and LHIP, indicating a reduction of IEG induction as current spreads. The
500µA group showed a significant increase in CCTX compared to RHIP. So we see the
drop off in current not only in the highest intensity group, but the lower levels as well.
This indicates that current intensities within our experiment range reduce their effects as
the current moves further away from stimulation site. A trend is also observed between
CCTX and LCTX region, where both cFos and zif268 in CCTX, showed the higher fold
change value than LCTX. This did not reach significance for cFos, but it follows the
pattern of decreasing fold change as the current moves from CCTX. So, not only can we
see the pattern in the highest intensity, but that this pattern is reiterated in the lower
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intensity groups. This evidence indicates that regardless of current intensity there is a
drop off in effects seen as you move further away from stimulation site.
The results indicate that as the current spreads, it loses its potential to cause IEG
induction and this is seen in the decrease in fold changes of IEGs across brain regions.
Other studies have modeled the spread of current in relation to human brain; and have
shown that the strongest concentration of current is under the electrode, and dissipates as
the current spreads across the brain28. We have demonstrated the spread of tDCS current
by means of IEG induction, and how the spread is related to current intensity. We
observe smaller mRNA levels in deeper brain regions, indicating there is less neuronal
activation.
A threshold current (2,000 µA) needs to be reached in order to observe effects in
HIP (changes compared to sham). The lower current intensities, 250 µA and 500 µA, did
not show significant change from sham in the hippocampus (Figure 14); indicating by the
time the current reached the hippocampus it was not sufficient enough to cause a change
in IEG levels. This is an important concept to understand, since targeting deeper regions
like the hippocampus is of interest to the research community. In order to target deeper
regions researchers need a sufficient current intensity that not only causes neuronal
activation but does not induce lesions.

Differential IEG Expression
This study showed that there is a differential expression of cFos and zif268 under
the same stimulation parameters. These genes show a difference in fold changes and a
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differential response due to stimulation environment. In this study both of these genes
responded to stimuli, but to different parameters. As shown in the awake animal
experiments, zif268 showed induction in both sham and 75 µA (Figure 8), indicating this
induction was due to novel object environment; but cFos was not induced. In the mRNA
experiments with varying current intensity, in which the animals were anesthetized, cFos
showed higher fold change values compared to zif268. Our results coincide with others
about the effects of anesthesia on zif268 expression. Researchers have looked at the
effects of tetanic stimulation under anesthesia; they reported a decrease in zif268
expression when compared to the awake animals29. So, the effect seen in our results may
be dampened by the use of anesthesia.
High frequency and theta burst stimulation is known to induce LTP29, 30, 31 and
there is a strong correlation with zif268 expression and LTP maintenance17, 31. Our
stimulation parameter is a constant current stimulation for 20 minutes for mRNA animals
and 60 minutes for immunohistochemical animals. Previous results indicate that zif268 is
highly expressed when there is LTP induction17. In case of our first experiment, in which
awake animals were placed in a novel object arena during stimulation; this could have
contributed to why we saw zif268 induction and not cFos. Researchers investigated
expression levels of cFos and zif268 with TMS treatment and how it was modulated with
different stimulation parameters9. They showed that current involving intermittent thetaburst throughout stimulation induced the expression of zif268, but not cFos when
compared against sham values9. With the theta burst paradigm, cFos expression was not
significantly different from sham stimulation in somatosensory cortex9. Now, in the same
study cFos showed strong induction with both high and low frequency current, which was
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not the case for zif268 expression9. This indicates that cFos induction is related to
stimulation alone, and not to LTP inducing stimulation. Interestingly, there is another
difference between zif268 and cFos induction; dependence on NMDA channel. Evidence
shows that zif268 is dependent on NMDA channel; in that with an addition of an NMDA
blocker, zif268 levels dropped significantly, whereas the cFos levels were unaffected32.
This coincides with the evidence above listing zif268 as being strongly correlated with
LTP maintenance17, 18. The difference in stimulation type could attribute to the
differences seen in experiment one.
Another factor that results in the differential expression of these two IEG’s is
auto-regulation. These two genes are different in that cFos auto- down regulates itself,
while zif268 auto-up regulates itself15, 33. The basal expression of zif268 is higher than
cFos, and cFos is induced at a much quicker rate, with the half-life of mRNA and
proteins approximately 10-15 minutes24. Other studies have conducted analyses
comparing cFos and zif268 levels, and have shown that basal levels of zif268 are larger
than cFos, and that the fold changes observed was larger for cFos than for zif2689. The
differences in fold changes could be related to the basal levels of zif268. This is seen with
our raw Ct values (data not shown) in which the cFos values were consistently higher
than the other targets, indicating a lower expression profile. The raw Ct values for zif268
were relatively closer to the endogenous control genes. With our evidence and other
researcher’s findings, this indicates that cFos has low basal expression and with induction
has a larger surge than that of zif268. This does not mean that cFos reacts more to the
stimulation; but explains the differential expression of cFos and zif268 in our
experiments.
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Dose response of current intensity
Our results indicated there is not a linear relationship between current intensity
and IEG induction or neuronal activation. The highest current intensity (2,000 µA)
consistently showed higher mRNA levels for both targets, but for protein expression
experiments with zif268 there was not a clear relationship between each of the currents
(Figures 9,10,11). There is a trend within our sets of experiments that show; as there is an
increase in current intensity, the percent of neurons expressing zif268 also increased.
Although within each immunohistochemistry set, there were no significant differences
between current intensity groups.
These results do not differ with results seen when other groups modulate current
intensity. It has been shown that when the current intensity was increased to 2,000 µA
cathodal current had an excitatory effect, which is the opposite effect conventionally
observed with cathodal stimulation25. Their data shows that when the current intensity is
above a threshold current value, that conventional results of tDCS stimulation do not
remain the same, meaning what is expected to be the outcome is not what occurs. A
similar effect was observed with our mRNA and protein results. For the zif268 protein
level expression, even though significance was not reached, the trend is not in a linear
fashion. In some cases the higher intensity displayed lower zif268 protein levels. For
cFos mRNA levels in the LCTX (Figure 13a), 250 µA showed a higher mRNA level than
500 µA. This trend was still observed in the hippocampus (Figure 14a). Also, for zif268
expression in the hippocampus, the 250 µA group also showed a larger fold change than
38

Distribution A: Approved for public release; distribution unlimited. 88ABW Cleared 07/14/2014; 88ABW-2014-3350

500 µA group. So, tDCS dose response does not seem to point towards a linear
relationship between current intensity and neuronal activation.
Another study showed a non-linear aspect of tDCS in which they increased the
time of stimulation and amount of time between two stimulations34. It showed that by
increasing stimulation duration from 13 minutes to 26 minutes, there was a decrease in
MEP output following tDCS. The hypothesis being that increasing stimulation time
would increase behavioral results; this was not the results observed34. This is similar to
the hypotheses of our study; higher current intensities will produce higher fold changes in
cFos and zif268. But, as seen with the results, this is not always the case.
We have shown that as current intensity increased it does not lead to a linear
increase in neuronal activation. This is shown with the mRNA and protein expression
level experiments, which show that in some regions the lower current intensity display
higher expression levels than higher intensities. This is important since we can add to the
understanding of dose response of tDCS, and that increasing the current may only be
beneficial up to some point. Also we have showed that there is an IEG induction
dependence on current intensity. Even though the relationship may not be in a linear
fashion, this shows that with different current intensities there will be differential
expression of neuronal activation markers

Lesions and Current Intensity
In experiment two we introduced variations in current intensity to induce lesions
to prove that we are getting current across the brain. A parallel experiment was run to
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examine the expression pattern of zif268 protein with the different current intensities. We
saw a trend that as the sets of animals increased in current intensity, the percent of
neurons expressing zif268 also increased. The H&E (Hematoxylin and Eosin) staining
(data not shown) shows that any current intensity above 500 µA produced visible lesions.
This data helped in determining the region of interest for experiments two and three, in
that we now had evidence pointing towards the path of the current. Because of the nature
of the lesion experiment, there was a small ‘n’ therefore making the criteria tighter in
order to find significance amongst the immunohistochemistry data.
In experiment three we saw that the 2000 µA group displayed the higher mRNA
levels for both cFos and zif268. This current intensity is in the range of lesions, indicating
that this high expression of the two IEG’s may be detrimental to the system. In some
regions for cFos the only other group to show significance against sham was 250 µA. The
lesions seen in experiment two were superficial, also indicating that the concentration of
current was the strongest in the outer layers of the cortex. This coincides with the data in
experiment three showing the highest mRNA levels were displayed in the CCTX.

Moving Forward
In this study we investigated fluctuations in expression levels of two IEG’s, cFos
and zif268, to determine how neuronal activation changes with current intensity. This
study was limited to two genes, but with further research we want to investigate more
gene targets. RNA sequencing allows researchers to see which pathways are involved
within the same reaction. Instead of investigating how 2 gene transcripts fluctuate with
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tDCS, researchers can investigate the transcriptome and see which are modulated due to
tDCS. In order to fully understand biological processes we need a more directive way to
pick out targets, and RNA sequencing allows for this direction.
Another question that arose during this project was differential expression of cFos
and zif268. Both of these transcripts, although they are transcribed quickly, they have
different temporal timelines to their transcription. By extending the time of tissue
collection we could outline the temporal transcription levels of these targets to determine
at which time they peak in expression levels. This would aid us in determining peak
transcript changes between groups if the tissue was collected at the appropriate time to
see the desired effect.
Researchers are also looking into the effects of repetitive tDCS34. Once we have
some more targets that are correlated with tDCS, we can view their fluctuations with
repetitive stimulation to see if there is an adaptation to stimulation. This is imperative to
know, since along with increasing current intensities, increasing the number of
stimulations may also not be beneficial.
With this baseline study completed, we are able to spring forward from the
existing data and monitor neuronal activation via cFos and zif268 to see how different
paradigms of stimulation affect the system. We want to determine a stimulation paradigm
that produces beneficial neuronal activation without causing lesions. In order to establish
conventional stimulation parameters, we need to better understand what is most
beneficial to the system.
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Conclusion
We have shown with this study that neuronal activation can be dependent upon
stimulation current intensities. With this knowledge we can move forward with other
gene targets and monitor their effects with tDCS treatment. Understanding the biological
effects of tDCS is imperative since this treatment is utilized in human subjects. This
study has identified targets that respond to tDCS, some are of interest to continue
studying while modifying the stimulation paradigm. Further studies need to be conducted
to elucidate further biological pathways involved with tDCS.
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Appendix

mRNA Level
Level 1
Group

ShamRHIP
cFos 250 µAHIP RHIP
500 µARHIP
2,000
µA-RHIP
ShamRHIP
250 µAzif268 RHIP
HIP 500 µARHIP
2,000
µA-RHIP

Level 2

Mean SEM Group

1.11
1.52
1.31
5.15
1.02
0.85
0.83
1.01

Mean SEM

Sham0.21 LHIP
250 µA0.27 LHIP
500 µA0.24 LHIP
2,000
0.73 µA-LHIP
Sham0.08 LHIP
250 µA0.05 LHIP
500 µA0.08 LHIP
2,000
0.03 µA-LHIP

Mean
Dif

Two-Tailed TwoSample t-test
p

DF t

1.15

0.25

-0.05

11

-0.13

0.90

1.31

0.19

0.21

14

0.62

0.55

1.48

0.16

-0.17

13

-0.53

0.61

3.68

0.39

1.47

13

1.71

0.11

1.01

0.06

0.01

11

0.06

0.95

0.99

0.04

-0.15

14

-2.17

0.05

0.88

0.04

-0.05

13

-0.50

0.63

1.16

0.03

-0.16

13

-3.81

0.00

Table 3: Two-tailed two sample t-test on RHIP
and LHIP samples
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